This pipeline uses various statistical tests to identify RPPAs whose expression levels correlated to selected clinical features.
Testing the association between 189 genes and 13 clinical features across 143 samples, statistically thresholded by Q value < 0.05, 6 clinical features related to at least one genes.
-
3 genes correlated to 'PATHOLOGY.T.STAGE'.
-
EIF4G1|EIF4G-R-C , DVL3|DVL3-R-V , EEF2K|EEF2K-R-V
-
2 genes correlated to 'GLEASON_SCORE_COMBINED'.
-
BCL2L11|BIM-R-V , SHC1|SHC_PY317-R-E
-
5 genes correlated to 'GLEASON_SCORE_PRIMARY'.
-
ESR1|ER-ALPHA_PS118-R-V , CCNB1|CYCLIN_B1-R-V , EIF4G1|EIF4G-R-C , MAPK14|P38_PT180_Y182-R-V , ERRFI1|MIG-6-M-V
-
4 genes correlated to 'GLEASON_SCORE'.
-
BCL2L11|BIM-R-V , EIF4G1|EIF4G-R-C , GAB2|GAB2-R-V , CCNB1|CYCLIN_B1-R-V
-
2 genes correlated to 'PSA_RESULT_PREOP'.
-
EEF2|EEF2-R-C , RAF1|C-RAF-R-V
-
20 genes correlated to 'DAYS_TO_PREOP_PSA'.
-
EGFR|EGFR_PY1173-R-V , RPS6|S6_PS235_S236-R-V , TSC2|TUBERIN_PT1462-R-V , RPS6|S6_PS240_S244-R-V , SRC|SRC_PY527-R-V , ...
-
No genes correlated to 'AGE', 'PATHOLOGY.N.STAGE', 'COMPLETENESS.OF.RESECTION', 'NUMBER.OF.LYMPH.NODES', 'GLEASON_SCORE_SECONDARY', 'PSA_VALUE', and 'DAYS_TO_PSA'.
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at Q value < 0.05.
Clinical feature | Statistical test | Significant genes | Associated with | Associated with | ||
---|---|---|---|---|---|---|
AGE | Spearman correlation test | N=0 | ||||
PATHOLOGY T STAGE | Spearman correlation test | N=3 | higher stage | N=3 | lower stage | N=0 |
PATHOLOGY N STAGE | t test | N=0 | ||||
COMPLETENESS OF RESECTION | ANOVA test | N=0 | ||||
NUMBER OF LYMPH NODES | Spearman correlation test | N=0 | ||||
GLEASON_SCORE_COMBINED | Spearman correlation test | N=2 | higher score | N=1 | lower score | N=1 |
GLEASON_SCORE_PRIMARY | Spearman correlation test | N=5 | higher score | N=4 | lower score | N=1 |
GLEASON_SCORE_SECONDARY | Spearman correlation test | N=0 | ||||
GLEASON_SCORE | Spearman correlation test | N=4 | higher score | N=4 | lower score | N=0 |
PSA_RESULT_PREOP | Spearman correlation test | N=2 | higher psa_result_preop | N=2 | lower psa_result_preop | N=0 |
DAYS_TO_PREOP_PSA | Spearman correlation test | N=20 | higher days_to_preop_psa | N=14 | lower days_to_preop_psa | N=6 |
PSA_VALUE | Spearman correlation test | N=0 | ||||
DAYS_TO_PSA | Spearman correlation test | N=0 |
Table S1. Basic characteristics of clinical feature: 'AGE'
AGE | Mean (SD) | 60.14 (7.1) |
Significant markers | N = 0 |
Table S2. Basic characteristics of clinical feature: 'PATHOLOGY.T.STAGE'
PATHOLOGY.T.STAGE | Mean (SD) | 2.65 (0.55) |
N | ||
2 | 55 | |
3 | 82 | |
4 | 5 | |
Significant markers | N = 3 | |
pos. correlated | 3 | |
neg. correlated | 0 |
Table S3. Get Full Table List of 3 genes significantly correlated to 'PATHOLOGY.T.STAGE' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
EIF4G1|EIF4G-R-C | 0.3602 | 1.067e-05 | 0.00202 |
DVL3|DVL3-R-V | 0.3391 | 3.656e-05 | 0.00687 |
EEF2K|EEF2K-R-V | 0.32 | 0.0001035 | 0.0194 |
Figure S1. Get High-res Image As an example, this figure shows the association of EIF4G1|EIF4G-R-C to 'PATHOLOGY.T.STAGE'. P value = 1.07e-05 with Spearman correlation analysis.

Table S4. Basic characteristics of clinical feature: 'PATHOLOGY.N.STAGE'
PATHOLOGY.N.STAGE | Labels | N |
class0 | 114 | |
class1 | 14 | |
Significant markers | N = 0 |
Table S5. Basic characteristics of clinical feature: 'COMPLETENESS.OF.RESECTION'
COMPLETENESS.OF.RESECTION | Labels | N |
R0 | 102 | |
R1 | 30 | |
RX | 3 | |
Significant markers | N = 0 |
Table S6. Basic characteristics of clinical feature: 'NUMBER.OF.LYMPH.NODES'
NUMBER.OF.LYMPH.NODES | Mean (SD) | 0.2 (0.75) |
Significant markers | N = 0 |
Table S7. Basic characteristics of clinical feature: 'GLEASON_SCORE_COMBINED'
GLEASON_SCORE_COMBINED | Mean (SD) | 7.31 (0.83) |
Score | N | |
6 | 9 | |
7 | 102 | |
8 | 12 | |
9 | 18 | |
10 | 2 | |
Significant markers | N = 2 | |
pos. correlated | 1 | |
neg. correlated | 1 |
Table S8. Get Full Table List of 2 genes significantly correlated to 'GLEASON_SCORE_COMBINED' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
BCL2L11|BIM-R-V | 0.3723 | 4.674e-06 | 0.000883 |
SHC1|SHC_PY317-R-E | -0.3108 | 0.0001579 | 0.0297 |
Figure S2. Get High-res Image As an example, this figure shows the association of BCL2L11|BIM-R-V to 'GLEASON_SCORE_COMBINED'. P value = 4.67e-06 with Spearman correlation analysis.

Table S9. Basic characteristics of clinical feature: 'GLEASON_SCORE_PRIMARY'
GLEASON_SCORE_PRIMARY | Mean (SD) | 3.51 (0.58) |
Score | N | |
2 | 1 | |
3 | 73 | |
4 | 64 | |
5 | 5 | |
Significant markers | N = 5 | |
pos. correlated | 4 | |
neg. correlated | 1 |
Table S10. Get Full Table List of 5 genes significantly correlated to 'GLEASON_SCORE_PRIMARY' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
ESR1|ER-ALPHA_PS118-R-V | 0.3493 | 1.902e-05 | 0.0036 |
CCNB1|CYCLIN_B1-R-V | 0.325 | 7.5e-05 | 0.0141 |
EIF4G1|EIF4G-R-C | 0.316 | 0.000121 | 0.0226 |
MAPK14|P38_PT180_Y182-R-V | -0.3131 | 0.0001407 | 0.0262 |
ERRFI1|MIG-6-M-V | 0.3077 | 0.000185 | 0.0342 |
Figure S3. Get High-res Image As an example, this figure shows the association of ESR1|ER-ALPHA_PS118-R-V to 'GLEASON_SCORE_PRIMARY'. P value = 1.9e-05 with Spearman correlation analysis.

Table S11. Basic characteristics of clinical feature: 'GLEASON_SCORE_SECONDARY'
GLEASON_SCORE_SECONDARY | Mean (SD) | 3.8 (0.64) |
Score | N | |
3 | 46 | |
4 | 79 | |
5 | 18 | |
Significant markers | N = 0 |
Table S12. Basic characteristics of clinical feature: 'GLEASON_SCORE'
GLEASON_SCORE | Mean (SD) | 7.37 (0.86) |
Score | N | |
6 | 9 | |
7 | 97 | |
8 | 14 | |
9 | 21 | |
10 | 2 | |
Significant markers | N = 4 | |
pos. correlated | 4 | |
neg. correlated | 0 |
Table S13. Get Full Table List of 4 genes significantly correlated to 'GLEASON_SCORE' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
BCL2L11|BIM-R-V | 0.4167 | 2.266e-07 | 4.28e-05 |
EIF4G1|EIF4G-R-C | 0.3272 | 6.639e-05 | 0.0125 |
GAB2|GAB2-R-V | 0.3078 | 0.0001844 | 0.0345 |
CCNB1|CYCLIN_B1-R-V | 0.3058 | 0.0002039 | 0.0379 |
Figure S4. Get High-res Image As an example, this figure shows the association of BCL2L11|BIM-R-V to 'GLEASON_SCORE'. P value = 2.27e-07 with Spearman correlation analysis.

Table S14. Basic characteristics of clinical feature: 'PSA_RESULT_PREOP'
PSA_RESULT_PREOP | Mean (SD) | 10.47 (9.9) |
Significant markers | N = 2 | |
pos. correlated | 2 | |
neg. correlated | 0 |
Table S15. Get Full Table List of 2 genes significantly correlated to 'PSA_RESULT_PREOP' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
EEF2|EEF2-R-C | 0.3556 | 1.512e-05 | 0.00286 |
RAF1|C-RAF-R-V | 0.3356 | 4.75e-05 | 0.00893 |
Figure S5. Get High-res Image As an example, this figure shows the association of EEF2|EEF2-R-C to 'PSA_RESULT_PREOP'. P value = 1.51e-05 with Spearman correlation analysis. The straight line presents the best linear regression.

Table S16. Basic characteristics of clinical feature: 'DAYS_TO_PREOP_PSA'
DAYS_TO_PREOP_PSA | Mean (SD) | -3.02 (56) |
Significant markers | N = 20 | |
pos. correlated | 14 | |
neg. correlated | 6 |
Table S17. Get Full Table List of top 10 genes significantly correlated to 'DAYS_TO_PREOP_PSA' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
EGFR|EGFR_PY1173-R-V | -0.4407 | 6.315e-08 | 1.19e-05 |
RPS6|S6_PS235_S236-R-V | 0.4086 | 6.532e-07 | 0.000123 |
TSC2|TUBERIN_PT1462-R-V | 0.3924 | 1.934e-06 | 0.000362 |
RPS6|S6_PS240_S244-R-V | 0.3889 | 2.43e-06 | 0.000452 |
SRC|SRC_PY527-R-V | 0.3873 | 2.696e-06 | 0.000499 |
MAPK1 MAPK3|MAPK_PT202_Y204-R-V | 0.3779 | 4.894e-06 | 9e-04 |
EIF4EBP1|4E-BP1_PT37_T46-R-V | 0.3668 | 9.667e-06 | 0.00177 |
RB1|RB_PS807_S811-R-V | 0.3645 | 1.11e-05 | 0.00202 |
MAPK1|ERK2-R-E | -0.3558 | 1.842e-05 | 0.00333 |
SRC|SRC_PY416-R-C | 0.3424 | 3.953e-05 | 0.00712 |
Figure S6. Get High-res Image As an example, this figure shows the association of EGFR|EGFR_PY1173-R-V to 'DAYS_TO_PREOP_PSA'. P value = 6.32e-08 with Spearman correlation analysis. The straight line presents the best linear regression.

Table S18. Basic characteristics of clinical feature: 'PSA_VALUE'
PSA_VALUE | Mean (SD) | 1.52 (4.6) |
Significant markers | N = 0 |
-
Expresson data file = PRAD-TP.rppa.txt
-
Clinical data file = PRAD-TP.merged_data.txt
-
Number of patients = 143
-
Number of genes = 189
-
Number of clinical features = 13
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.